According to Sarah, RVX will be offering a webcast in Q1 2016. Although RVX still hasn't updated their events page to reflect their Q1 schedule, RVX is presenting Feb 8-9, 2016 in New York City at the BIO CEO and Investor Conference. At last year's BIO CEO and Investor Conference, RVX did offer a webcast as documented in this new release. This conference is about 3 weeks away. My guess is that we're getting a webcast from this conference, but that's just a guess.

As Chicagoest stated, "we must patiently wait for another catalyst to awaken the masses." It sure would be nice to hear about the status of the PHN orphan trial, an update on BETonMACE enrollment and the FDA, the status of these rumored 2016 scientific publications, RVX-208 follow on molecules, Alzheimer's trial planning, any additional kidney trials, anything new from the Emerald Logic Facet analysis, update on further research with the RVX-208 patient blood bank, more regional licensing deals, etc. etc.

BearDownAZ